These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 22061641)

  • 1. The discovery of novel cyclohexylamide CCR2 antagonists.
    Lanter JC; Markotan TP; Zhang X; Subasinghe N; Kang FA; Hou C; Singer M; Opas E; McKenney S; Crysler C; Johnson D; Molloy CJ; Sui Z
    Bioorg Med Chem Lett; 2011 Dec; 21(24):7496-501. PubMed ID: 22061641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of INCB3344, a potent, selective and orally bioavailable antagonist of human and murine CCR2.
    Xue CB; Wang A; Meloni D; Zhang K; Kong L; Feng H; Glenn J; Huang T; Zhang Y; Cao G; Anand R; Zheng C; Xia M; Han Q; Robinson DJ; Storace L; Shao L; Li M; Brodmerkel CM; Covington M; Scherle P; Diamond S; Yeleswaram S; Vaddi K; Newton R; Hollis G; Friedman S; Metcalf B
    Bioorg Med Chem Lett; 2010 Dec; 20(24):7473-8. PubMed ID: 21036044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel 2-aminooctahydrocyclopentalene-3a-carboxamides as potent CCR2 antagonists.
    Cai C; Kang FA; Hou C; O'Neill JC; Opas E; McKenney S; Johnson D; Sui Z
    Bioorg Med Chem Lett; 2013 Jan; 23(1):351-4. PubMed ID: 23182090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The design and synthesis of novel, potent and orally bioavailable N-aryl piperazine-1-carboxamide CCR2 antagonists with very high hERG selectivity.
    Cumming JG; Bower JF; Waterson D; Faull A; Poyser PJ; Turner P; McDermott B; Campbell AD; Hudson J; James M; Winter J; Wood C
    Bioorg Med Chem Lett; 2012 Jun; 22(12):3895-9. PubMed ID: 22608963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of potent, orally bioavailable small-molecule inhibitors of the human CCR2 receptor.
    Doyon J; Coesemans E; Boeckx S; Buntinx M; Hermans B; Van Wauwe JP; Gilissen RA; De Groot AH; Corens D; Van Lommen G
    ChemMedChem; 2008 Apr; 3(4):660-9. PubMed ID: 18188859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. QSAR studies on CCR2 antagonists with chiral sensitive hologram descriptors.
    Nair PC; Srikanth K; Sobhia ME
    Bioorg Med Chem Lett; 2008 Feb; 18(4):1323-30. PubMed ID: 18258426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 4-Azetidinyl-1-heteroatom linked cyclohexane antagonists of CCR2: patent evaluation.
    Horuk R; Guilford W
    Expert Opin Ther Pat; 2011 Aug; 21(8):1275-80. PubMed ID: 21554155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of 3-phenylsulfonylmethyl cyclohexylaminobenzamide-derived antagonists of CC chemokine receptor 2 (CCR2).
    Yang MG; Xiao Z; Shi Q; Cherney RJ; Tebben AJ; De Lucca GV; Santella JB; Mo R; Cvijic ME; Zhao Q; Barrish JC; Carter PH
    Bioorg Med Chem Lett; 2012 Feb; 22(3):1384-7. PubMed ID: 22225639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of 3-piperidinyl-1-cyclopentanecarboxamide as a novel scaffold for highly potent CC chemokine receptor 2 antagonists.
    Yang L; Butora G; Jiao RX; Pasternak A; Zhou C; Parsons WH; Mills SG; Vicario PP; Ayala JM; Cascieri MA; MacCoss M
    J Med Chem; 2007 May; 50(11):2609-11. PubMed ID: 17461566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of novel 2-(aminoheteroaryl)-thiazole-5-carboxamides as potent and orally active Src-family kinase p56(Lck) inhibitors.
    Chen P; Norris D; Das J; Spergel SH; Wityak J; Leith L; Zhao R; Chen BC; Pitt S; Pang S; Shen DR; Zhang R; De Fex HF; Doweyko AM; McIntyre KW; Shuster DJ; Behnia K; Schieven GL; Barrish JC
    Bioorg Med Chem Lett; 2004 Dec; 14(24):6061-6. PubMed ID: 15546730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, structure-activity relationship and in vivo antiinflammatory efficacy of substituted dipiperidines as CCR2 antagonists.
    Xia M; Hou C; DeMong DE; Pollack SR; Pan M; Brackley JA; Jain N; Gerchak C; Singer M; Malaviya R; Matheis M; Olini G; Cavender D; Wachter M
    J Med Chem; 2007 Nov; 50(23):5561-3. PubMed ID: 17929797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overcoming hERG activity in the discovery of a series of 4-azetidinyl-1-aryl-cyclohexanes as CCR2 antagonists.
    Zhang X; Hufnagel H; Markotan T; Lanter J; Cai C; Hou C; Singer M; Opas E; McKenney S; Crysler C; Johnson D; Sui Z
    Bioorg Med Chem Lett; 2011 Sep; 21(18):5577-82. PubMed ID: 21783361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of pyrrolo[2,1-f][1,2,4]triazine C6-ketones as potent, orally active p38α MAP kinase inhibitors.
    Dyckman AJ; Li T; Pitt S; Zhang R; Shen DR; McIntyre KW; Gillooly KM; Shuster DJ; Doweyko AM; Sack JS; Kish K; Kiefer SE; Newitt JA; Zhang H; Marathe PH; McKinnon M; Barrish JC; Dodd JH; Schieven GL; Leftheris K
    Bioorg Med Chem Lett; 2011 Aug; 21(15):4633-7. PubMed ID: 21705217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of novel, potent, selective, and orally active human glucagon receptor antagonists containing a pyrazole core.
    Shen DM; Brady EJ; Candelore MR; Dallas-Yang Q; Ding VD; Feeney WP; Jiang G; McCann ME; Mock S; Qureshi SA; Saperstein R; Shen X; Tong X; Tota LM; Wright MJ; Yang X; Zheng S; Chapman KT; Zhang BB; Tata JR; Parmee ER
    Bioorg Med Chem Lett; 2011 Jan; 21(1):76-81. PubMed ID: 21147532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potent hFPRL1 (ALXR) agonists as potential anti-inflammatory agents.
    Bürli RW; Xu H; Zou X; Muller K; Golden J; Frohn M; Adlam M; Plant MH; Wong M; McElvain M; Regal K; Viswanadhan VN; Tagari P; Hungate R
    Bioorg Med Chem Lett; 2006 Jul; 16(14):3713-8. PubMed ID: 16697190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological profile of JNJ-27141491 [(S)-3-[3,4-difluorophenyl)-propyl]-5-isoxazol-5-yl-2-thioxo-2,3-dihydro-1H-imidazole-4-carboxyl acid methyl ester], as a noncompetitive and orally active antagonist of the human chemokine receptor CCR2.
    Buntinx M; Hermans B; Goossens J; Moechars D; Gilissen RA; Doyon J; Boeckx S; Coesemans E; Van Lommen G; Van Wauwe JP
    J Pharmacol Exp Ther; 2008 Oct; 327(1):1-9. PubMed ID: 18599682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and biological evaluation of phenyl piperidine derivatives as CCR2 antagonists.
    Xia M; Hou C; Pollack S; Brackley J; DeMong D; Pan M; Singer M; Matheis M; Olini G; Cavender D; Wachter M
    Bioorg Med Chem Lett; 2007 Nov; 17(21):5964-8. PubMed ID: 17869105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent developments in CCR2 antagonists.
    Xia M; Sui Z
    Expert Opin Ther Pat; 2009 Mar; 19(3):295-303. PubMed ID: 19441905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel, orally bioavailable gamma-aminoamide CC chemokine receptor 2 (CCR2) antagonists.
    Pasternak A; Marino D; Vicario PP; Ayala JM; Cascierri MA; Parsons W; Mills SG; Maccoss M; Yang L
    J Med Chem; 2006 Aug; 49(16):4801-4. PubMed ID: 16884289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and structure-activity relationship of 7-azaindole piperidine derivatives as CCR2 antagonists.
    Xia M; Hou C; DeMong D; Pollack S; Pan M; Singer M; Matheis M; Murray W; Cavender D; Wachter M
    Bioorg Med Chem Lett; 2008 Dec; 18(24):6468-70. PubMed ID: 18990568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.